We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Boston Beer
SAM
$1.81B
| $282K | ﹤0.01% |
956
+41
| +4% | +$11.2K |
|
1577
Atmos Energy
ATO
$29.8B
| $281K | ﹤0.01% |
2,734
-11,351
| -81% | -$1.11M |
|
1578
Myers Industries
MYE
$1.16B
| $281K | ﹤0.01% |
16,431
-1,978
| -11% | -$33.6K |
|
1579
Qorvo
QRVO
$7.89B
| $280K | ﹤0.01% |
3,909
-4,074
| -51% | -$270K |
|
1580
Texas Capital Bancshares
TCBI
$4.49B
| $278K | ﹤0.01% |
5,097
-263
| -5% | -$15.2K |
|
1581
Hawkins
HWKN
$2.99B
| $277K | ﹤0.01% |
15,026
+1,850
| +14% | +$37.8K |
|
1582
Orthofix Medical
OFIX
$445M
| $277K | ﹤0.01% |
4,918
+662
| +16% | +$37.2K |
|
1583
Bank OZK
OZK
$5.56B
| $276K | ﹤0.01% |
9,541
-3,053
| -24% | -$92.4K |
|
|
INVX
1584
Innovex International
INVX
$1.9B
| $276K | ﹤0.01% |
+6,016
| New | +$236K |
|
1585
Viper Energy
VNOM
$8.84B
| $275K | ﹤0.01% |
+8,300
| New | +$266K |
|
1586
Calumet Specialty Products
CLMT
$3.85B
| $274K | ﹤0.01% |
77,053
-4,000
| -5% | -$13.3K |
|
1587
Affiliated Managers Group
AMG
$9.16B
| $272K | ﹤0.01% |
2,535
-337
| -12% | -$35.8K |
|
|
NTUS
1588
DELISTED
Natus Medical Inc
NTUS
| $272K | ﹤0.01% |
10,736
+2,509
| +30% | +$74.9K |
|
1589
REX American Resources
REX
$1.54B
| $269K | ﹤0.01% |
19,992
-1,974
| -9% | -$25K |
|
|
PRFT
1590
DELISTED
Perficient Inc
PRFT
| $269K | ﹤0.01% |
9,803
-1,952
| -17% | -$51.4K |
|
1591
Camden Property Trust
CPT
$11.1B
| $268K | ﹤0.01% |
2,645
-1,537
| -37% | -$148K |
|
1592
Great Southern Bancorp
GSBC
$847M
| $268K | ﹤0.01% |
5,180
+111
| +2% | +$5.89K |
|
|
OSG
1593
Octave Specialty Group
OSG
$263M
| $267K | ﹤0.01% |
14,743
-2,272
| -13% | -$43.4K |
|
1594
KLX Energy Services
KLXE
$45.8M
| $267K | ﹤0.01% |
2,126
+61
| +3% | +$8.09K |
|
1595
Ameris Bancorp
ABCB
$6.05B
| $266K | ﹤0.01% |
7,752
+597
| +8% | +$22.2K |
|
|
CTXS
1596
DELISTED
Citrix Systems Inc
CTXS
| $266K | ﹤0.01% |
2,670
-6,079
| -69% | -$630K |
|
|
DHC
1597
Diversified Healthcare Trust
DHC
$2.25B
| $265K | ﹤0.01% |
22,499
+2,367
| +12% | +$30.3K |
|
1598
Evertec
EVTC
$1.8B
| $265K | ﹤0.01% |
9,530
+742
| +8% | +$21K |
|
1599
Globus Medical
GMED
$10.2B
| $264K | ﹤0.01% |
+5,353
| New | +$242K |
|
1600
Rithm Capital
RITM
$5.1B
| $264K | ﹤0.01% |
15,617
-22,667
| -59% | -$373K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.